IDEXX Laboratories, Inc. (IDXX) Tops Q1 EPS by 2c; Increases FY11 EPS Outlook
IDEXX Laboratories, Inc. (NASDAQ: IDXX) reported Q1 EPS of $0.62, $0.02 better than the analyst estimate of $0.60. Revenue for the quarter came in at $292.7 million versus the consensus estimate of $285.61 million.
Increases FY11 EPS outlook from $2.62 - $2.68 to $2.66 - $2.71, versus the consensus of $2.66. Also sees FY11 revenue of $1.205 - $1.215 billion, versus the consensus of $1.19 billion.
Increases FY11 EPS outlook from $2.62 - $2.68 to $2.66 - $2.71, versus the consensus of $2.66. Also sees FY11 revenue of $1.205 - $1.215 billion, versus the consensus of $1.19 billion.